Sanders Morris Harris LLC Eli Lilly & CO Transaction History

Sanders Morris Harris LLC

  • $585 Million
  • Q3 2024

A detailed history of Sanders Morris Harris LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sanders Morris Harris LLC holds 9,840 shares of LLY stock, worth $9.02 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
9,840
Previous 9,842 0.02%
Holding current value
$9.02 Million
Previous $8.91 Million 2.17%
% of portfolio
1.49%
Previous 1.5%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024
SELL
$772.14 - $960.02 $1,544 - $1,920
-2 Reduced 0.02%
9,840 $8.72 Million
Q2 2024

Jul 12, 2024
SELL
$724.87 - $909.04 $1,449 - $1,818
-2 Reduced 0.02%
9,842 $8.91 Million
Q1 2024

Apr 11, 2024
BUY
$592.2 - $792.28 $3.93 Million - $5.26 Million
6,644 Added 207.63%
9,844 $7.66 Million
Q4 2023

Jan 10, 2024
SELL
$525.19 - $619.13 $3.56 Million - $4.2 Million
-6,776 Reduced 67.92%
3,200 $1.87 Million
Q3 2023

Oct 13, 2023
BUY
$434.7 - $599.3 $1.39 Million - $1.92 Million
3,200 Added 47.23%
9,976 $5.36 Million
Q3 2023

Oct 05, 2023
SELL
$434.7 - $599.3 $1.4 Million - $1.93 Million
-3,219 Reduced 32.21%
6,776 $3.64 Million
Q2 2023

Jul 10, 2023
BUY
$350.74 - $468.98 $1.12 Million - $1.5 Million
3,205 Added 47.2%
9,995 $4.69 Million
Q1 2023

Apr 07, 2023
SELL
$310.63 - $364.82 $994,016 - $1.17 Million
-3,200 Reduced 32.03%
6,790 $2.33 Million
Q4 2022

Jan 12, 2023
SELL
$321.55 - $374.67 $1,929 - $2,248
-6 Reduced 0.06%
9,990 $0
Q3 2022

Oct 07, 2022
SELL
$296.48 - $337.87 $1,185 - $1,351
-4 Reduced 0.04%
9,996 $3.23 Million
Q2 2022

Jul 11, 2022
SELL
$278.73 - $327.27 $3,344 - $3,927
-12 Reduced 0.12%
10,000 $3.24 Million
Q1 2022

Apr 11, 2022
SELL
$234.69 - $291.66 $3,989 - $4,958
-17 Reduced 0.17%
10,012 $2.87 Million
Q4 2021

Feb 02, 2022
SELL
$224.85 - $279.04 $27,881 - $34,600
-124 Reduced 1.22%
10,029 $2.75 Million
Q3 2021

Oct 13, 2021
SELL
$221.6 - $272.71 $2,437 - $2,999
-11 Reduced 0.11%
10,153 $2.35 Million
Q2 2021

Jul 13, 2021
SELL
$180.55 - $233.54 $2,708 - $3,503
-15 Reduced 0.15%
10,164 $2.35 Million
Q1 2021

Apr 19, 2021
BUY
$164.32 - $212.72 $1.15 Million - $1.48 Million
6,979 Added 218.09%
10,179 $1.89 Million
Q1 2021

Apr 14, 2021
SELL
$164.32 - $212.72 $1.15 Million - $1.49 Million
-6,994 Reduced 68.61%
3,200 $583,000
Q4 2020

Jan 26, 2021
SELL
$130.46 - $172.63 $1,826 - $2,416
-14 Reduced 0.14%
10,194 $1.78 Million
Q3 2020

Oct 16, 2020
BUY
$146.22 - $169.13 $376,955 - $436,017
2,578 Added 33.79%
10,208 $1.52 Million
Q2 2020

Jul 09, 2020
BUY
$136.42 - $164.18 $1.04 Million - $1.25 Million
7,630 New
7,630 $1.25 Million
Q1 2020

Apr 09, 2020
SELL
$119.05 - $147.35 $1.52 Million - $1.88 Million
-12,736 Closed
0 $0
Q4 2019

Jan 09, 2020
BUY
$106.92 - $132.43 $5,025 - $6,224
47 Added 0.37%
12,736 $1.67 Million
Q2 2019

Jul 10, 2019
BUY
$110.79 - $129.32 $548,742 - $640,521
4,953 Added 64.03%
12,689 $1.41 Million
Q1 2019

Apr 19, 2019
SELL
$111.31 - $131.02 $45,859 - $53,980
-412 Reduced 5.06%
7,736 $1 Million
Q4 2018

Jan 14, 2019
BUY
$105.9 - $118.64 $2,965 - $3,321
28 Added 0.34%
8,148 $943,000
Q3 2018

Oct 10, 2018
BUY
$85.86 - $107.31 $622,399 - $777,890
7,249 Added 832.26%
8,120 $871,000
Q3 2018

Oct 09, 2018
SELL
$85.86 - $107.31 $656,227 - $820,170
-7,643 Reduced 89.77%
871 $871,000
Q3 2017

Oct 23, 2017
BUY
$77.07 - $85.54 $656,173 - $728,287
8,514
8,514 $728,000

Others Institutions Holding LLY

# of Institutions
3,886
Shares Held
750M
Call Options Held
6.34M
Put Options Held
7.97M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $871B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sanders Morris Harris LLC Portfolio

Follow Sanders Morris Harris LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Morris Harris LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email